Trial Profile
A Double-Blind, Placebo-Controlled, Randomised Dose Ranging Trial to Investigate the Efficacy of Two Different Dosing Regimens of Avotermin (Juvista) in the Improvement of Scar Appearance When Applied to Approximated Wound Margins in Healthy Volunteers.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 May 2014
Price :
$35
*
At a glance
- Drugs Avotermin (Primary)
- Indications Scars
- Focus Therapeutic Use
- Sponsors Renovo
- 20 May 2014 New trial record